GILD has been removed from your Stock Email Alerts list.
Please enter Portfolio Name for new portfolio.
This is the historical short interest of Gilead Sciences Inc, as measured by the Short Percentage Of Float.
This the Institutional Ownership History of Gilead Sciences IncPeter Lynch prefers to buy companies with low institutional ownership.
This is the historical insider ownership of Gilead Sciences Inc. It is usually better to buy companies with large insider ownership. The company insiders' interest are more aligned with external shareholders in this case.
|Holder||Position||Shares||% of Shares |
|Dr. John C. Martin,M.D.||Chairman and CEO||4,122,987||0.27%||2015-01-02|
|Dr. John F. Milligan,PhD||President and COO||974,048||less than 0.1%||2014-12-08|
|Mr. Etienne F. Davignon||Director||836,273||less than 0.1%||2014-05-06|
|Dr. Gordon Moore,M.D.||Director||709,498||less than 0.1%||2012-05-12|
|Kevin Young||N/A||216,418||less than 0.1%||2014-01-23|
|James M. Denny||Director||210,060||less than 0.1%||2012-12-31|
|Mark L. Perry||EVP Operations||196,040||less than 0.1%||2004-02-03|
|Dr. Taiyin Yang||SVP, Pharm Dev & Mfg||146,381||less than 0.1%||2007-05-02|
|Dr. Norbert W. Bischofberger, PhD||EVP, R&D and CSO||119,302||less than 0.1%||2015-01-15|
|Mr. Gregg H. Alton||EVP, Corp & Med Affairs||113,694||less than 0.1%||2015-01-08|
|Holder||Shares||Report Date||% of Shares |
|% of Total |
|Capital Research Global Investors||122,275,884||2014-09-30||8.08||4.51||13,016,268,000|
|Fidelity Management and Research Company||88,347,923||2014-09-30||5.84||1.33||9,404,636,000|
|Vanguard Group, Inc.||79,280,967||2014-09-30||5.24||0.66||8,439,459,000|
|State Street Corp||62,176,203||2014-09-30||4.11||0.71||6,618,668,000|
|T. Rowe Price Associates, Inc.||58,913,323||2014-09-30||3.89||1.37||6,271,323,000|
|BlackRock Fund Advisors||46,826,033||2014-09-30||3.09||0.74||4,984,631,000|
|VA CollegeAmerica Growth Fund of America||34,135,148||2014-12-31||2.26||2.36||3,217,579,050|
|VA CollegeAmerica Invmt Co of America||26,975,605||2014-12-31||1.79||3.61||2,542,720,527|
|Capital World Investors||26,457,190||2014-09-30||1.75||0.79||2,816,368,000|
|Vanguard Total Stock Mkt Idx||25,424,252||2014-12-31||1.69||0.63||2,396,489,994|